Back to Search
THILAGAVATHI VENKATACHALAM, MD
MD
Nephrology Physician
NPI: 1124213442IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
FELMD2021-059(NM)69779(AZ)R9160(TX)170785(FL)
CMS Specialties
PrimaryNEPHROLOGY
Education
OTHER
Class of 2000
Research & Publications (20)
Execution of superoxide-induced cell death by the proapoptotic Bcl-2-related proteins Bid and Bak.
PMID 19332555·Mol Cell Biol·2009
7-preclinical
In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443).
PMID 17515292·Arzneimittelforschung·2007
7-preclinical
In vivo pharmacokinetics, metabolism, toxicity, and anti-HIV activity of N'-[2-(2-Thiophene)ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase.
PMID 17803063·Arzneimittelforschung·2007
7-preclinical
Large-scale synthesis of GMP grade alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13), a new anti-cancer drug candidate.
PMID 17469650·Arzneimittelforschung·2007
8-other
Improved oral bioavailability of anti-HIV agent N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443) in a novel lipophilic formulation.
PMID 17469651·Arzneimittelforschung·2007
7-preclinical
Large-scale synthesis of GMP grade N'- [2-(2-thiophene) ethyl]-N'- [2- (5-bromopyridyl)] -thiourea (HI-443), a new anti-HIV drug candidate.
PMID 17688078·Arzneimittelforschung·2007
8-other
Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.
PMID 17396622·Arzneimittelforschung·2007
8-other
Preclinical toxicity and pharmacokinetics of the Bruton's tyrosine kinase-targeting anti-leukemic drug candidate, alpha-cyano-beta-hydroxy-beta-methyl-N- (2,5-dibromophenyl) propenamide (LFM-A13).
PMID 17341007·Arzneimittelforschung·2007
7-preclinical
Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
PMID 17688077·Arzneimittelforschung·2007
7-preclinical
N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activity.
PMID 17598700·Arzneimittelforschung·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 3821 MASTHEAD ST NE
ALBUQUERQUE, NM 87109 - Phone
- (505) 998-7400
Quick Facts
- NPI
- 1124213442
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 4
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile